MedPath

The effect of aerobic exercise on cardiac inflammatory factors in diabetic wome

Not Applicable
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20200729048252N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
36
Inclusion Criteria

Women in the age range of 35 to 50 years
They develop type 2 diabetes by measuring their fasting glucose twice (mean above 125 mg / dL) and having it approved by a doctor.
Body mass index higher than 25 and less than 30 kg / m2
Lack of cardiovascular disease
Lack of regular physical exercise in the last year
No restrictions or physical problems to participate in the training program

Exclusion Criteria

Failure to sign informed written consent
Smoking and alcohol at least once a week
Pregnancy and lactation
Menopause
Hyper tention
Liver and kidney failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pentraxine 3. Timepoint: Before training protocols and 12 weeks later (after training protocols are completed). Method of measurement: Using the ELISA laboratory kit.;Cardiotrophin 1. Timepoint: Before training protocols and 12 weeks later (after training protocols are completed. Method of measurement: Using the ELISA laboratory kit.;Galactin 3. Timepoint: Before training protocols and 12 weeks later (after training protocols are completed. Method of measurement: Using the ELISA laboratory kit.;Interleukin 6. Timepoint: Before training protocols and 12 weeks later (after training protocols are complet. Method of measurement: Using the ELISA laboratory kit.
Secondary Outcome Measures
NameTimeMethod
Glucose. Timepoint: Before training protocols and 12 weeks later (after training protocols are completed). Method of measurement: Pars Azmoun Company Kit.;Insulin. Timepoint: Before training protocols and 12 weeks later (after training protocols are completed). Method of measurement: Insulin ELISA Kit.;Insulin resistance. Timepoint: Before training protocols and 12 weeks later (after training protocols are completed). Method of measurement: Evaluation of homeostasis model (HOMA-IR).
© Copyright 2025. All Rights Reserved by MedPath